Thursday, July 09, 2015

          New Leadership at the UCSF/UC Hastings Consortium on Law, Science and Health Policy

          On July 1st, the Consortium welcomed new Co-Director Professor Jaime King, taking over from Professor David Faigman.
          Sample alt tag.

          After seven years, Professor and Associate Dean David L. Faigman has stepped down as the founding director of the UCSF/UC Hastings Consortium on Law, Science & Health Policy.

          UC Hastings Professor Jaime King will take the helm as the new co-director for the Consortium, working with her counterparts at UCSF to lead the organization.

          The Consortium was established in 2008, with the mission to develop and support collaborative educational and professional opportunities for students and faculty at UC Hastings and UCSF. The organization brings together the two leading institutions by utilizing research, clinical training, and service to promote interdisciplinary collaboration at the intersection of law, science and health policy.

          “I still remember the day Professor Shauna Marshall asked me to lead the UC Hastings side of this historic partnership,” recalled Faigman. “I am extremely honored and privileged to have directed this remarkable collaboration with one of the greatest universities in the world.”

          Under Faigman’s leadership the Consortium has achieved major milestones including signing a formal agreement with UCSF, creating the health law concentration, founding the Masters of Studies in Law (MSL) program, and establishing the Medical-Legal Partnership for Seniors (MLPS), among other accomplishments.

          “Even though David’s day-to-day role will change, the positive impact of his years as Director will continue,” said Professor Lois A. Weithorn. “He put much of his own scholarly agenda on the back burner for many years to provide to UC Hastings this extraordinary service of building the Consortium.”

          Faigman, the John F. Digardi Distinguished Professor of Law, will return to teaching full-time this fall but still has plans to remain active with the Consortium.

          “I could not be more proud of how far the Consortium has come, and I could not be more enthusiastic and confident about where it is going,” said Faigman.

          “It was wonderful to watch David lead the creation of these programs. The work he has done began years ago and has generated so much for the two institutions,” said Chancellor & Dean Frank H. Wu. “I look forward to the continued success of Professor Jaime King, who is another true star in the field.”

          Formerly the Associate Director of the Consortium, Professor Jaime King assumed the post of Director on July 1, 2015. She is looking forward to furthering the dynamic and path-breaking work Professor Faigman began. “It is such an honor to have the opportunity to work with groundbreaking scholars in law and medicine to help improve health care in America. The Consortium is uniquely positioned to drive change by promoting the use of innovative medical and health services research in law and policy. David should be extremely proud of his vision and all that he has created.”

          As co-director, King hopes to develop a community of UCSF and UC Hastings students, faculty, and alumni eager to contribute to the Consortium through education, research, and service. “The Consortium creates an opportunity to bring amazing people together to solve some of the most challenging problems facing our nation’s health care system. I am thrilled that I am able to be a part of that and to share those opportunities with the broader UC Hastings community.”

          Go to News Archive

          Share this Story

          Share via Facebook
          Share via TwitterShare via EmailPrint Friendly Version

          Other Recent Stories/ RSS

          Monday, November 20, 2017

          Professor Carol Izumi receives 2018 William Pincus Award for Outstanding Service and Commitment to Clinical Legal Education from the Association of American Law Schools (AALS)

          “Recipients are giants in the field and Carol belongs in their midst,” says Associate Dean Ascanio Piomelli.
          Friday, November 17, 2017

          Exciting New Spring 2018 Courses Focus on the Future

          Grabbing from the headlines and emphasizing innovation, courses like Legal Tech Startups, Advanced Immigration Law, and Stalking and Law will prepare UC Hastings students for next-level legal careers.
          Tuesday, November 14, 2017

          Port pilot John Betz ’96 discusses his non-legal career and the importance of education

          A tragic “Deadliest Catch” moment piqued a lifelong interest in the law and encouraged John to pursue a law degree at UC Hastings.
          Friday, November 03, 2017

          Thinkers & Doers: October 2017

          100 Things Warriors Fans Should Know & Do Before They Die -- Alum appointed Chargé d’Affaires -- The poisonous dynamic over who’s to blame for racism -- Prof. Williams on the Harvey Weinstein Effect -- Two More UC Hastings Grads Receive Judgeships from Gov. Brown -- Jury selection in the Steinle case -- and much more
          Wednesday, November 01, 2017

          Why do drug prices remain so high?

          "Because drug companies block competition," says Professor Feldman in a new study that examines all drugs on the market between 2005 and 2015, identifying and analyzing every instance in which the company added new patents or exclusivities. 
          Go to News Archive